首页 / 院系成果 / 成果详情页

microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma  期刊论文  

  • 编号:
    296b565c-0108-48af-b4f4-5f7b7315f9fe
  • 作者:
  • 语种:
    英文
  • 期刊:
    FEBS LETTERS ISSN:0014-5793 2011 年 585 卷 12 期 (1828 - 1834) ; JUN 23
  • 收录:
  • 关键词:
  • 摘要:

    Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with poor prognosis. Sorafenib, a multikinase inhibitor, has been widely used to treat patients with advanced HCC in clinic. We postulated that microRNAs (miRNA) might be involved in HCC target-chemotherapy with sorafenib. MiRNA profile of HepG2 was evaluated after cells were treated with vehicle or sorafenib and alterations in miRNA expression occurred with 14 miRNAs. MiR-1274a, which is up-regulated by sorafenib, could significantly repress expression of ADAM9, a protease that is involved in sorafenib target-therapy of HCC, in HCC cells. Taken together, our data emphasizes a new miRNA-based mechanism of sorafenib antitumor therapy. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

  • 推荐引用方式
    GB/T 7714:
    Zhou Changchun,Liu Jibing,Li Yang, et al. microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma [J].FEBS LETTERS,2011,585(12):1828-1834.
  • APA:
    Zhou Changchun,Liu Jibing,Li Yang,Liu Li,&Yuan Qipeng.(2011).microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma .FEBS LETTERS,585(12):1828-1834.
  • MLA:
    Zhou Changchun, et al. "microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma" .FEBS LETTERS 585,12(2011):1828-1834.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:5 下载次数:0
浏览次数:5
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部